Treatment Options for Patients with Recurrent Tumors After BCG Therapy: Are We Ignoring the Obvious?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 29685644.
- Also identified by DOI 10.1016/j.eururo.2018.04.012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Treatment options are limited for non-muscle-invasive bladder cancer patients having failed BCG treatment who cannot undergo cystectomy. While results from ongoing clinical trials are awaited, data have emerged suggesting that combination of agents having previously demonstrated safety and efficacy in this setting can help a large percentage of our patients. These data should not be ignored.
Medical subject headings
- BCG Vaccine
- Carcinoma, Transitional Cell
- Cystectomy
- Doxorubicin
- Neoplasm Recurrence, Local
- Urinary Bladder Neoplasms